{"id":228124,"date":"2023-06-06T04:49:07","date_gmt":"2023-06-06T04:49:07","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=228124"},"modified":"2023-06-06T04:49:07","modified_gmt":"2023-06-06T04:49:07","slug":"dopamine-receptor-antagonists","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/","title":{"rendered":"Dopamine receptor antagonists"},"content":{"rendered":"<div class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654] sm:AIPRM__conversation__response\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-4 whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<p>In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-228124","post","type-post","status-publish","format-standard","hentry","category-d"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dopamine receptor antagonists - Definition of Dopamine receptor antagonists<\/title>\n<meta name=\"description\" content=\"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dopamine receptor antagonists - Definition of Dopamine receptor antagonists\" \/>\n<meta property=\"og:description\" content=\"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-06T04:49:07+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/\",\"name\":\"Dopamine receptor antagonists - Definition of Dopamine receptor antagonists\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-06-06T04:49:07+00:00\",\"dateModified\":\"2023-06-06T04:49:07+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dopamine receptor antagonists\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dopamine receptor antagonists - Definition of Dopamine receptor antagonists","description":"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/","og_locale":"en_US","og_type":"article","og_title":"Dopamine receptor antagonists - Definition of Dopamine receptor antagonists","og_description":"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/","og_site_name":"Glossary","article_published_time":"2023-06-06T04:49:07+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/","name":"Dopamine receptor antagonists - Definition of Dopamine receptor antagonists","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-06-06T04:49:07+00:00","dateModified":"2023-06-06T04:49:07+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"In the realm of pharmaceuticals, there exists a preceding category of antipsychotic medications, commonly referred to as neuroleptics. These particular drugs exert their primary effect by obstructing the receptor sites on nerve cells that are typically responsible for receiving the neurotransmitter dopamine within the brain.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-receptor-antagonists\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Dopamine receptor antagonists"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/228124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=228124"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/228124\/revisions"}],"predecessor-version":[{"id":228125,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/228124\/revisions\/228125"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=228124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=228124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=228124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}